Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:1979-1984
Published online before print June 17, 2004, doi: 10.1161/01.STR.0000133691.07945.f2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/8/1979    most recent
01.STR.0000133691.07945.f2v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gendron, A.
Right arrow Articles by Teitelbaum, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gendron, A.
Right arrow Articles by Teitelbaum, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Pathology of Stroke

(Stroke. 2004;35:1979.)
© 2004 American Heart Association, Inc.


Original Contributions

Transient Middle Cerebral Artery Occlusion Influence on Systemic Oxygen Homeostasis and Erythropoiesis in Wistar Rats

Alain Gendron, MSc, DESS; Edouard Kouassi, PhD; Stephen Nuara, DEC; Chantal Cossette, DEC; Giovanni D’Angelo, BSc, FCMLS; David Geadah, MSc; Patrick du Souich, MD, PhD Jeanne Teitelbaum, MD

From the Guy-Bernier Research Center (A.G., E.K., S.N., C.C., G.D., D.G.), Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; the Departments of Pharmacology (A.G., P.d.S.) and Medicine (E.K.), University of Montreal, Quebec, Canada; and the Montreal Neurological Hospital and McGill University (J.T.), Montreal, Quebec, Canada.

Correspondence to Dr Jeanne Teitelbaum, Montreal Neurological Hospital, 3801 University Ave, C/O Lucille Orchard, Montreal, Quebec, H3A-2B4. E-mail jteitelbaum{at}hotmail.com

Background and Purpose— Systemic hypoxia is a common complication in stroke patients and may exacerbate ischemic brain damage. Expression of the hypoxia-inducible cytokine erythropoietin (Epo) is upregulated in the brain in both stroke patients and in animal stroke models and exerts local neuroprotective effects in the ischemic brain. Epo is also well known to stimulate red blood cell (RBC) production. The purpose of the present study was to evaluate whether poststroke systemic hypoxia is present in the rat model and whether it is associated with increased peripheral Epo and RBC production.

Methods— Wistar rats underwent 1-hour transient middle cerebral artery occlusion (MCAO) under mechanical ventilation, followed by reperfusion without further ventilation. Groups of MCAO and sham-operated animals were evaluated at extended times after reperfusion for assessment of arterial blood gases, plasma Epo, and complete blood count.

Results— Arterial oxygen saturation was significantly lower in the infarct group between 6 and 24 hours after reperfusion (P=0.0005), and plasma Epo levels were increased 6 hours after reperfusion (P<0.05). RBC counts and hematocrit were transiently increased 2 to 7 days after reperfusion in animals with MCAO compared with sham. Maximal increases were seen at day 7 (22% and 16% increases of RBC count and hematocrit, respectively; P<0.001). In contrast, the white blood cell counts in animals with MCAO decreased by >30% in the same time period.

Conclusions— Plasma Epo levels, RBC counts, and hematocrit are all increased in response to systemic hypoxia after cerebral ischemia in rats.


Key Words: hypoxia • hematocrit • stroke